Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2004-004136-31Phase 3Completed
Phase 3, randomised trial of progesterone in preterm birth (3 arms), sponsored by Laboratorios Effik. Primary endpoint: Global prematurity rate (<37 weeks). Started May 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2004-004136-31.